Guideline on shared facilities coming into effect 01 June 2015

 

 

 

  • December 1st 2015 : For medicinal products introduced for the first time into shared manufacturing facilities.

  • June 1st 2016 : For manufacturers of products for human use already produced in shared manufacturing facilities (unless existing arrangements scientiffically justified) including those who manufacture human and veterinary medicines using shared manufacturing facilities.

  • June 1st 2017 : For manufacturers solely producing products for veterinary use (unless existing arrangements scientiffically justified) .

To fullfill guideline on shared facilities requirements within the deadlines imposed, we elaborate some customized PDE monographs for all products concerned. Access directly to our database which contains more than 1,000 PDEs already developed.

Latest news

CPhI 2017

Socosur Chem is exhibiting again on Indis Associates (of which Exim Corp.) botth 80F02. An...(...)

AZIERTA exclusive agency for INDIA

The Azierta Socosur agreement on PDE, OEL, ICHQ and other toxicology services have been extended to...(...)

New Service - ICH Q3D

New competitive service as part of Azierta cooperation: ICH Q3D – Elemental i...(...)

Exclusive agency for Azierta PDE monographs

Azierta and Socosur just entered an exclusive agency agreement for PDE monographs elaborated by...(...)

Stay in touch

Contact us